Key result
Systematic access to renal function information for community pharmacists will be evaluated in a cluster randomized trial of 1,920 DOAC users to assess its impact on clinically relevant bleeding.
Why the study?
Does providing community pharmacists with systematic access to patients' renal function information reduce clinically relevant bleeding in DOAC users?
Population
1920 patients using direct oral anticoagulants for the management of thromboembolic diseases across 96…
Comparison
Systematic access to patients' renal function… vs Usual care
Design
RCT, Cluster randomized (allocated into two groups: intervention and control)
Follow-up
6 months
Authors
Loading...
May improve bleeding safety for DOAC users if effective; leaves open whether pharmacist renal data access reduces clinically relevant bleeding.
RCT (n=1,920)
cluster
Yes
Does providing community pharmacists with systematic access to patients' renal function information reduce clinically relevant bleeding in DOAC users?
Badran et al. (2026) conducted an RCT in Direct oral anticoagulant (DOAC) users (n=1,920). Systematic access to renal function information vs. Usual care was evaluated on Occurrence of clinically relevant bleeding—major and nonmajor—occurring within three months after DOACs dispensing. Systematic access to renal function information for community pharmacists will be evaluated in a cluster randomized trial of 1,920 DOAC users to assess its impact on clinically relevant bleeding.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: